Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sahin

Showing results (331-340 of 454) with videos related to

Pageof 46
Sort By:
Virchows Archiv : an International Journal of Pathology|May 7, 2025
Upregulation of MMP9 expression in postradiation angiosarcoma of the breast: a possible predictive risk factorQingqing Ding, Phyu P Aung, Hongxia Sun, et al.
Cancer|January 19, 2010
Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : long-term results from the University of Texas M. D. Anderson Cancer Center Study ID97-099Ricardo H Alvarez, Daniel J Booser, Massimo Cristofanilli, et al.
Cancer|September 29, 2011
Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline- and nonanthracycline-based regimens for HER2-positive breast cancerSoley Bayraktar, Ana M Gonzalez-Angulo, Xiudong Lei, et al.
Cancer|May 25, 2005
Improving local control with breast-conserving therapy: a 27-year single-institution experienceNeslihan Cabioglu, Kelly K Hunt, Thomas A Buchholz, et al.
Histopathology|July 8, 2024
MYB expression by immunohistochemistry is highly specific and sensitive for detection of solid variant of adenoid cystic carcinoma of the breast among all triple-negative breast cancersHarsh Batra, Priya S C Bose, Yang Ding, et al.
Carcinogenesis|September 15, 2016
Aurora kinase-A overexpression in mouse mammary epithelium induces mammary adenocarcinomas harboring genetic alterations shared with human breast cancerWarapen Treekitkarnmongkol, Hiroshi Katayama, Kazuharu Kai, et al.
Annals of Surgery|April 16, 2011
Delays in primary surgical treatment are not associated with significant tumor size progression in breast cancer patientsJamie L Wagner, Carla L Warneke, Elizabeth A Mittendorf, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 25, 2000
Novel translational model for breast cancer chemoprevention study: accrual to a presurgical intervention with tamoxifen and N-[4-hydroxyphenyl] retinamideE Singletary, R Lieberman, N Atkinson, et al.
Clinical Breast Cancer|March 16, 2024
Comparison of PD-L1 (22C3) Expression in Paired Primary and Metastatic Breast CarcinomaXiao Huang, Sarah A Anderson, Gene P Siegal, et al.
AJR. American Journal of Roentgenology|November 23, 2006
Comparison of full-field digital mammography and screen-film mammography for detection and characterization of simulated small massesWei T Yang, Chao-Jen Lai, Gary J Whitman, et al.
Pageof 46

Showing results (331-340 of 454) with videos related to

Sort By:
Pageof 46
Virchows Archiv : an International Journal of Pathology|May 7, 2025
Upregulation of MMP9 expression in postradiation angiosarcoma of the breast: a possible predictive risk factorQingqing Ding, Phyu P Aung, Hongxia Sun, et al.
Cancer|January 19, 2010
Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : long-term results from the University of Texas M. D. Anderson Cancer Center Study ID97-099Ricardo H Alvarez, Daniel J Booser, Massimo Cristofanilli, et al.
Cancer|September 29, 2011
Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline- and nonanthracycline-based regimens for HER2-positive breast cancerSoley Bayraktar, Ana M Gonzalez-Angulo, Xiudong Lei, et al.
Cancer|May 25, 2005
Improving local control with breast-conserving therapy: a 27-year single-institution experienceNeslihan Cabioglu, Kelly K Hunt, Thomas A Buchholz, et al.
Histopathology|July 8, 2024
MYB expression by immunohistochemistry is highly specific and sensitive for detection of solid variant of adenoid cystic carcinoma of the breast among all triple-negative breast cancersHarsh Batra, Priya S C Bose, Yang Ding, et al.
Carcinogenesis|September 15, 2016
Aurora kinase-A overexpression in mouse mammary epithelium induces mammary adenocarcinomas harboring genetic alterations shared with human breast cancerWarapen Treekitkarnmongkol, Hiroshi Katayama, Kazuharu Kai, et al.
Annals of Surgery|April 16, 2011
Delays in primary surgical treatment are not associated with significant tumor size progression in breast cancer patientsJamie L Wagner, Carla L Warneke, Elizabeth A Mittendorf, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 25, 2000
Novel translational model for breast cancer chemoprevention study: accrual to a presurgical intervention with tamoxifen and N-[4-hydroxyphenyl] retinamideE Singletary, R Lieberman, N Atkinson, et al.
Clinical Breast Cancer|March 16, 2024
Comparison of PD-L1 (22C3) Expression in Paired Primary and Metastatic Breast CarcinomaXiao Huang, Sarah A Anderson, Gene P Siegal, et al.
AJR. American Journal of Roentgenology|November 23, 2006
Comparison of full-field digital mammography and screen-film mammography for detection and characterization of simulated small massesWei T Yang, Chao-Jen Lai, Gary J Whitman, et al.
Pageof 46